As Memorial Day marks the unofficial start of summer and the mercury hits nearly 100 in Washington, "The Tan Sheet" is here to keep you up to date on the latest hot news in the OTC and nutritionals industries.
Here in Washington, the American Academy of Pediatricians turns up the heat on its bid to eliminate combination OTC pediatric products, including those containing acetaminophen and Rep. Darrell Issa raises the temperature of his criticism of FDA for its handling of recalls from a McNeil Consumer Healthcare plant in Puerto Rico. Overseas, Johnson & Johnson heats up in Eastern Europe with the purchase of several Russian OTC bands from J.B. Chemicals & Pharmaceuticals.
TOP STORIES
Pfizer Consumer Chief Sees Chronic Conditions In OTC Future
Future OTC switches of drugs for chronic conditions like high cholesterol could "fundamentally help" alter the health care environment and lower costs, says Pfizer Consumer Healthcare President Paul Sturman.
AAP Presses FDA To Eliminate OTC Pediatric Combination Products
The American Academy of Pediatrics wants FDA to eliminate OTC combination pediatric cough/cold products.
J&J Expands Russian OTC Foothold Via J.B. Chemicals Portfolio Acquisition
Johnson & Johnson expands its consumer health presence in Russia and other Eastern European markets with the acquisition of several OTC brands from J.B. Chemicals & Pharmaceuticals.
(Stay on top of all the hottest OTC and nutritional industry news with "The Tan Sheet." Click here for a free 30-day trial.)
Continue reading "This Week In OTCs And Nutritionals: Heating Up Edition" »


